• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Charts / Financials

2.63% ! 19.5¢
Market Cap $46.30M  !
Healthcare Biotechnology
Add to My Watchlist

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

refresh Created with Sketch. REFRESH
Last update - 11.10am 11/09/2025 (20 minute delay) ?
Day
Open 19.0¢   Day High 19.5¢   Day Low 18.0¢
Daily Volume 289331
Bids   Sellers
Number Price Volume   Number Price Volume
1 19.0¢ 83333   2 19.5¢ 4869

Directors & Senior Management

Dr. Kilian Kelly Chief Executive Officer, Managing Director, Director
Dr. Suzanne Lipe Vice President - Partner Engagement
Dr. Jolanta Airey Chief Medical Officer
Dr. Mathias Kroll Chief Business Officer
Mr. Peter Gordon Webse Company Secretary
Dr. Geoffrey E. D. Brooke Independent Non-Executive Chairman of the Board
Ms. Janine Rolfe Director
Dr. Darryl Maher Non-Executive Independent Director
Dr. Paul K. Wotton Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
19.5¢ 		Change
0.005(2.63%) 		Mkt cap ! $46.30M
Open High Low Value Volume
19.0¢ 19.5¢ 18.0¢ $53.29K 289.3K

Buyers (Bids)

No. Vol. Price($)
1 83333 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 4869 2
View Market Depth
Last trade - 15.02pm 11/09/2025 (20 minute delay) ?
Last
19.0¢ 		  Change
0.005 ( 0.00 %)
Open High Low Volume
18.5¢ 19.0¢ 18.0¢ 184584
Last updated 11.10am 11/09/2025 ?

Top Stories

EV Resources snaps up Nevada antimony project; will raise $5.5M for it, Los Lirios

EV Resources has come out of its halt with a bang, unveiling the acquisition of the Dollar Antimony Project in Nye County alongside a raise.
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
Afterpay owner Block shares dip after competitor Klarna lists 30% higher out the gate Afterpay owner Block has seen its shares head towards a -3% drop as the market digests news of Klarna's successful U.S. IPO overnight.
EVR opens strong with funding, acquisition, and sales agreement announcements EVR has caught attention on the HotCopper forums and across the wider Australian markets today with a flurry of announcements.
Market Close: Aussie traders divorce from US as retreat continues. At least there's 4DX Good Afternoon and welcome to HotCopper’s Market Close for Thursday 11th of September, I’m Jon Davidson. We’ve truly diverted from Wall Street at the start of September with the local bourse retreating once again this week, showing an Australian inv...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.